Cargando…
COVID-19 in a patient treated with eculizumab for aquaporin-4 neuromyelitis optica
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076662/ https://www.ncbi.nlm.nih.gov/pubmed/33904965 http://dx.doi.org/10.1007/s00415-021-10578-7 |
| _version_ | 1783684728233132032 |
|---|---|
| author | Cabal-Herrera, Ana Maria Mateen, Farrah J. |
| author_facet | Cabal-Herrera, Ana Maria Mateen, Farrah J. |
| author_sort | Cabal-Herrera, Ana Maria |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8076662 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80766622021-04-27 COVID-19 in a patient treated with eculizumab for aquaporin-4 neuromyelitis optica Cabal-Herrera, Ana Maria Mateen, Farrah J. J Neurol Letter to the Editors Springer Berlin Heidelberg 2021-04-27 2021 /pmc/articles/PMC8076662/ /pubmed/33904965 http://dx.doi.org/10.1007/s00415-021-10578-7 Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editors Cabal-Herrera, Ana Maria Mateen, Farrah J. COVID-19 in a patient treated with eculizumab for aquaporin-4 neuromyelitis optica |
| title | COVID-19 in a patient treated with eculizumab for aquaporin-4 neuromyelitis optica
|
| title_full | COVID-19 in a patient treated with eculizumab for aquaporin-4 neuromyelitis optica
|
| title_fullStr | COVID-19 in a patient treated with eculizumab for aquaporin-4 neuromyelitis optica
|
| title_full_unstemmed | COVID-19 in a patient treated with eculizumab for aquaporin-4 neuromyelitis optica
|
| title_short | COVID-19 in a patient treated with eculizumab for aquaporin-4 neuromyelitis optica
|
| title_sort | covid-19 in a patient treated with eculizumab for aquaporin-4 neuromyelitis optica |
| topic | Letter to the Editors |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076662/ https://www.ncbi.nlm.nih.gov/pubmed/33904965 http://dx.doi.org/10.1007/s00415-021-10578-7 |
| work_keys_str_mv | AT cabalherreraanamaria covid19inapatienttreatedwitheculizumabforaquaporin4neuromyelitisoptica AT mateenfarrahj covid19inapatienttreatedwitheculizumabforaquaporin4neuromyelitisoptica |